Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig
暂无分享,去创建一个
Robert Landsiedel | Franz Oesch | F. Oesch | E. Fabian | R. Landsiedel | Eric Fabian | Christoph Werner | Barbara Oesch-Bartlomowicz | C. Werner | B. Oesch-Bartlomowicz
[1] Jagdish Singh,et al. Effect of buffer pH, buffer concentration and skin with or without enzyme inhibitors on the stability of [Arg(8)]-vasopressin. , 2000, International journal of pharmaceutics.
[2] T. Hardingham,et al. The tissue content and turnover rates of intermediates in the biosynthesis of glycosaminoglycans in young rat skin. , 1968, The Biochemical journal.
[3] Elaine Fuchs,et al. Stem cells of the skin epithelium , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Rawlins,et al. Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasis , 1980, The British journal of dermatology.
[5] J Kao,et al. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. , 1985, Toxicology and applied pharmacology.
[6] J. Zatz,et al. Effect of formulation on the delivery and metabolism of alpha-tocopheryl acetate. , 2001, Journal of cosmetic science.
[7] A. Kalofoutis,et al. Influence of oral isotretinoin on hepatic and cutaneous P-450-dependent isozyme activities , 1994, Archives of Dermatological Research.
[8] A. Pfeifer,et al. Cytochrome P450 expression and related metabolism in human buccal mucosa. , 2001, Carcinogenesis.
[9] F. Oesch,et al. Sequence of a novel cytochrome CYP2B cDNA coding for a protein which is expressed in a sebaceous gland, but not in the liver. , 1992, The Biochemical journal.
[10] J. Höög,et al. Expression and localization of human alcohol and aldehyde dehydrogenase enzymes in skin. , 1999, Biochemical and biophysical research communications.
[11] B. Lacarelle,et al. Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposure. , 2002, Toxicology and applied pharmacology.
[12] R. Kato,et al. Purification and characterization of four catalytically active testosterone 6 beta-hydroxylase P-450s from rat liver microsomes: comparison of a novel form with three structurally and functionally related forms. , 1990, Journal of biochemistry.
[13] F. Guengerich,et al. Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. , 1993, Journal of medicinal chemistry.
[14] S. Kitamura,et al. Xanthine oxidase-catalyzed metabolism of 2-nitrofluorene, a carcinogenic air pollutant, in rat skin. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[15] H. Korting,et al. Prednicarbate Biotransformation in Human Foreskin Keratinocytes and Fibroblasts , 1997, Pharmaceutical Research.
[16] A. Cherniack,et al. Clotrimazole, an inhibitor of epidermal benzo(a)pyrene metabolism and DNA binding and carcinogenicity of the hydrocarbon. , 1984, Cancer research.
[17] J. Maclouf,et al. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. , 1996, Experimental cell research.
[18] S. Penco,et al. Induction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.
[19] E. Jabs,et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. , 1994, The Journal of biological chemistry.
[20] F. Guengerich,et al. Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. , 1995, Chemical research in toxicology.
[21] Jeffrey B. Cheng,et al. De-orphanization of Cytochrome P450 2R1 , 2003, Journal of Biological Chemistry.
[22] H. Mukhtar,et al. Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. , 1984, The Journal of investigative dermatology.
[23] G. Ferron,et al. Quantitation of cytochrome P450 mRNA levels in human skin. , 2003, Analytical biochemistry.
[24] F. Oesch,et al. Mechanisms of Toxification and Detoxification which Challenge Drug Candidates and Drugs , 2007 .
[25] H. Mukhtar,et al. Inhibition of epidermal metabolism and DNA-binding of benzo[a]pyrene by ellagic acid. , 1983, Biochemical and biophysical research communications.
[26] S. Georgiou,et al. Effects of Human Recombinant Interferon-α2b on P450-Dependent Isozymes in Rat Liver and Skin , 1995 .
[27] J. Masferrer,et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. , 1998, Carcinogenesis.
[28] J. Saurat,et al. Topical β‐carotene is converted to retinyl esters in human skin ex vivo and mouse skin in vivo , 2004, Experimental dermatology.
[29] Jane Huggins. Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin. , 2003 .
[30] A. Stinchcomb. Xenobiotic Bioconversion in Human Epidermis Models , 2003, Pharmaceutical Research.
[31] Gillian Smith,et al. Localization of Cytochrome P450 CYP2S1 Expression in Human Tissues by In Situ Hybridization and Immunohistochemistry , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[32] B. Buzadžić,et al. Doxorubicin toxicity to the skin: possibility of protection with antioxidants enriched yeast. , 2001, Journal of dermatological science.
[33] A. Weston,et al. Metabolism and activation of benzo[a]pyrene by mouse and rat skin in short-term organ culture and in vivo. , 1982, Chemico-biological interactions.
[34] H. Blom,et al. Altered status of glutathione and its metabolites in cystinotic cells. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] G. Clawson,et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). , 2003, The Journal of investigative dermatology.
[36] C. Gomez-Sanchez,et al. Gas chromatography/mass spectrometry characterization of corticosteroid metabolism in human immortalized keratinocytes. , 2002, The Journal of investigative dermatology.
[37] R. Agarwal,et al. Cytochrome P-450 and drug development for skin diseases. , 1996, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[38] D. Galter,et al. Tissue- and species-specific expression patterns of class I, III, and IV Adh and Aldh1 mRNAs in rodent embryos , 2005, Cell and Tissue Research.
[39] L. Perry,et al. Delayed repair: the role of glutathione in a rat incisional wound model. , 1996, The Journal of surgical research.
[40] P. Parvaz,et al. Thiram-induced cytotoxicity is accompanied by a rapid and drastic oxidation of reduced glutathione with consecutive lipid peroxidation and cell death. , 2001, Toxicology.
[41] A. Sakr,et al. Characterization of Esterase and Alcohol Dehydrogenase Activity in Skin. Metabolism of Retinyl Palmitate to Retinol (Vitamin A) During Percutaneous Absorption , 1994, Pharmaceutical Research.
[42] F. Oesch,et al. Functional heterogeneity of UDP-glucuronyltransferase in rat tissues. , 1980, Biochemical pharmacology.
[43] H. Merk,et al. Multiple Cytochrome P450–Isoenzymes mRNA Are Expressed in Dendritic Cells , 1999, International Archives of Allergy and Immunology.
[44] D. Jerina,et al. Role of cytochrome P450 enzyme induction in the metabolic activation of benzo[c]phenanthrene in human cell lines and mouse epidermis. , 1997, Chemical research in toxicology.
[45] Y. Y. Wang,et al. Disubstituted amino-, nitroso-, and nitrofluorenes: a physicochemical basis for structure-activity relationships in Salmonella typhimurium. , 1987, Environmental mutagenesis.
[46] G. Siest,et al. Reconstituted epidermis: a novel model for the study of drug metabolism in human epidermis. , 1990, The Journal of investigative dermatology.
[47] B. Conway,et al. Skin delivery potency and antitumor activities of temozolomide ester prodrugs. , 2006, Cancer letters.
[48] A. R. Thitoff,et al. Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology , 2004, International journal of toxicology.
[49] H. Mukhtar,et al. Glutathione S-transferases in human and rodent skin: multiple forms and species-specific expression. , 1991, The Journal of investigative dermatology.
[50] R. J. Anderson,et al. Sulfation of minoxidil by multiple human cytosolic sulfotransferases. , 1998, Chemico-biological interactions.
[51] M. Rawlins,et al. Drug Metabolism in Skin , 1980 .
[52] L. Kopelovich,et al. Cyclooxygenases in the skin: pharmacological and toxicological implications. , 2003, Toxicology and applied pharmacology.
[53] T. Abe,et al. Characterization of Vitamin D-mediated induction of the CYP 24 transcription , 2004, Molecular and Cellular Endocrinology.
[54] H. Merk,et al. Die Wirkung kleinmolekularer Substanzen auf die menschliche Haut , 2004, Der Hautarzt.
[55] P. Swaan,et al. Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin. , 2002, Journal of pharmaceutical sciences.
[56] M. Negishi,et al. The structure, function, and regulation of cytochrome P450 2A enzymes. , 1997, Drug metabolism reviews.
[57] H. Mukhtar,et al. Drug metabolism in skin. Comparative activity of the mixed-function oxidases, epoxide hydratase, and glutathione S-transferase in liver and skin of the neonatal rat. , 1981, Drug metabolism and disposition: the biological fate of chemicals.
[58] M. Meurer,et al. Conversion of vitamin D3 to 1α,25‐dihydroxyvitamin D3 in human skin equivalents , 2000 .
[59] K. Wittern,et al. Comparison of Activities Dependent on Glutathione S-Transferase and Cytochrome P-450 IA1 in Cultured Keratinocytes and Reconstructed Epidermal Models , 2002, Skin Pharmacology and Physiology.
[60] H. Merk,et al. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. , 2007, The Journal of investigative dermatology.
[61] P. Zaphiropoulos,et al. The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. , 2000, Genomics.
[62] N. Fusenig,et al. Induction of UDP-glucuronyltransferase and arylhydrocarbon hydroxylase activity in mouse skin and in normal and transformed skin cells in culture. , 1986, Biochemical pharmacology.
[63] H. Mukhtar,et al. Effect of topical application of clotrimazole to rats on epidermal and hepatic monooxygenase activities and cytochrome P-450 , 2004, Archives of Dermatological Research.
[64] R. Bronaugh,et al. Percutaneous Absorption and Metabolism of Coumarin in Human and Rat Skin , 1997, Journal of applied toxicology : JAT.
[65] J. Heylings,et al. Percutaneous absorption and metabolism of dinitrochlorobenzene in vitro , 2000, Archives of Toxicology.
[66] D. Bikle,et al. Vitamin D, calcium, and epidermal differentiation. , 1993, Endocrine reviews.
[67] A. Conney,et al. Inducibility of benzo [α] pyrene hydroxylase in human skin by polycyclic hydrocarbons , 1973, Clinical pharmacology and therapeutics.
[68] M. Waterman,et al. A Keratinocyte-specific Epoxygenase, CYP2B12, Metabolizes Arachidonic Acid with Unusual Selectivity, Producing a Single Major Epoxyeicosatrienoic Acid* , 1998, The Journal of Biological Chemistry.
[69] M. Taimi,et al. A Novel Human Cytochrome P450, CYP26C1, Involved in Metabolism of 9-cis and All-trans Isomers of Retinoic Acid* , 2004, Journal of Biological Chemistry.
[70] D. Hinshaw,et al. Oxidant stress: the role of the glutathione redox cycle in skin preconditioning. , 1995, The Journal of surgical research.
[71] S. Frankenberg,et al. Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. , 2001, The Journal of investigative dermatology.
[72] D. Howes,et al. TOXICOKINETICS AND METABOLISM , 2005 .
[73] Liping Du,et al. Differentiation-Specific Factors Modulate Epidermal CYP1–4 Gene Expression in Human Skin in Response to Retinoic Acid and Classic Aryl Hydrocarbon Receptor Ligands , 2006, Journal of Pharmacology and Experimental Therapeutics.
[74] W. Baschong,et al. Direct evidence for bioconversion of vitamin E acetate into vitamin E: an ex vivo study in viable human skin. , 2001, Journal of cosmetic science.
[75] Camilla K. Smith,et al. Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. , 2000, Toxicology and applied pharmacology.
[76] F. Oesch,et al. Epoxides derived from various polycyclic hydrocarbons as substrates of homogeneous and microsome-bound epoxide hydratase. A general assay and kinetic properties. , 1976, European journal of biochemistry.
[77] H. Mukhtar,et al. Purification and characterization of NADPH‐cytochrome P‐450 reductase from rat epidermis , 1993, Journal of cellular biochemistry.
[78] A. Guillouzo,et al. In Vitro expression of drug metabolizing enzyme activities in human adult keratinocytes under various culture conditions and their response to inducers. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.
[79] H. Mukhtar,et al. Skin as a Portal of Entry for Systemic Effect: Xenobiotic Metabolism , 1990 .
[80] H. Mukhtar,et al. Human hair follicle benzo[a]pyrene and benzo[a]pyrene 7,8-diol metabolism: effect of exposure to a coal tar-containing shampoo. , 1987, The Journal of investigative dermatology.
[81] H. Merk,et al. N-Acetylation of paraphenylenediamine in human skin and keratinocytes. , 2000, The Journal of pharmacology and experimental therapeutics.
[82] R. Agarwal,et al. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[83] R. Serda,et al. Expression, structure‐function, and molecular modeling of vitamin D P450s , 2003, Journal of cellular biochemistry.
[84] F. Watt,et al. Cell shape controls terminal differentiation of human epidermal keratinocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[85] G. Aldini,et al. Detoxification of 4-hydroxynonenal (HNE) in keratinocytes: characterization of conjugated metabolites by liquid chromatography/electrospray ionization tandem mass spectrometry. , 2003, Journal of mass spectrometry : JMS.
[86] Dooley Tp. Molecular biology of the human cytosolic sulfotransferase gene superfamily implicated in the bioactivation of minoxidil and cholesterol in skin. , 1999 .
[87] F. Oesch,et al. Studies of the expression of the cytochrome P450IA, P450IIB, and P450IIC gene family in extrahepatic and hepatic tissues. , 1990, Environmental health perspectives.
[88] Gillian Smith,et al. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases , 2003, The Lancet.
[89] S. Hoffman,et al. Epidermal CYP2 family cytochromes P450. , 2004, Toxicology and applied pharmacology.
[90] R. Bronaugh,et al. Influence of metabolism in skin on dosimetry after topical exposure. , 1994, Environmental health perspectives.
[91] S. Hotchkiss,et al. Species variations in cutaneous alcohol dehydrogenases and aldehyde dehydrogenases may impact on toxicological assessments of alcohols and aldehydes. , 2003, Toxicology.
[92] A. Hiratsuka,et al. Marked expression of glutathione S-transferase A4-4 detoxifying 4-hydroxy-2(E)-nonenal in the skin of rats irradiated by ultraviolet B-band light (UVB). , 1999, Biochemical and biophysical research communications.
[93] A. Yarat,et al. The effect of Glurenorm (gliquidone) on lenses and skin in experimental diabetes. , 2001, Free radical biology & medicine.
[94] R. Edwards,et al. Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. , 2002, Biochemical and biophysical research communications.
[95] A. Haberland,et al. The impact of skin viability on drug metabolism and permeation -- BSA toxicity on primary keratinocytes. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.
[96] A. Kulkarni,et al. Peroxidase, an alternate pathway to cytochrome P-450 for xenobiotic metabolism in skin: partial purification and properties of the enzyme from neonatal rat skin. , 1986, Journal of biochemical toxicology.
[97] P. Woster,et al. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. , 2000, The Journal of investigative dermatology.
[98] S. Hotchkiss,et al. Comparativein VitroSkin Absorption and Metabolism of Coumarin (1,2-Benzopyrone) in Human, Rat, and Mouse , 1997 .
[99] B. Bonnekoh,et al. Induction and inhibition of NAD(P)H: quinone reductase in murine and human skin. , 1991, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[100] R. Bronaugh,et al. Metabolism of xenobiotics during percutaneous penetration: role of absorption rate and cutaneous enzyme activity. , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[101] A. Haberland,et al. Cutaneous Estradiol Permeation, Penetration and Metabolism in Pig and Man , 2004, Skin Pharmacology and Physiology.
[102] F. Oesch,et al. Antibodies against homogeneous epoxide hydratase provide evidence for a single enzyme hydrating styrene oxide and benz(a)pyrene 4,5-oxide , 1976, Nature.
[103] B. De Wever,et al. Expression of type 1 5α‐reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic®): a new model for screening skin‐targeted androgen modulators , 2000, International journal of cosmetic science.
[104] H. Mukhtar,et al. Epidermal enzyme-mediated mutagenicity of the skin carcinogen, 2-aminoanthracene. , 1985, Mutation research.
[105] D. Howes,et al. Percutaneous penetration and dermal metabolism of triclosan (2,4, 4'-trichloro-2'-hydroxydiphenyl ether). , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[106] K. Sugibayashi,et al. Simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin after its topical application: the effect of enzyme distribution in skin. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[107] C. Esser,et al. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. , 2003, The Journal of investigative dermatology.
[108] C. Chesné,et al. Culture and drug biotransformation capacity of adult human keratinocytes from post‐mortem skin , 1996, The British journal of dermatology.
[109] Allan B. Okey,et al. Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.
[110] B. Shroot,et al. Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytes , 1995, The British journal of dermatology.
[111] H. Mukhtar,et al. Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat. , 1989, The Journal of pharmacology and experimental therapeutics.
[112] H. Maibach,et al. Metabolism of 3-indolylacetic acid during percutaneous absorption in human skin. , 1993, Journal of pharmaceutical sciences.
[113] K. Wong,et al. Sulphate conjugation of minoxidil in rat skin. , 1993, Biochemical pharmacology.
[114] P. Janssen,et al. Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole. , 1988, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[115] J. Hornung,et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.
[116] T. Kumaravel,et al. In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N'-diacetyl metabolites. , 2006, Mutation research.
[117] R. Bronaugh,et al. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. , 1989, Toxicology and applied pharmacology.
[118] David E. Williams,et al. Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: II. Expression and Role of Flavin-Containing Monooxygenases and Peroxidases , 2006, Journal of Pharmacology and Experimental Therapeutics.
[119] S. Georgiou,et al. Effects of human recombinant interferon-alpha 2b on P450-dependent isozymes in rat liver and skin. , 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[120] M. Taimi,et al. CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes ω- and (ω-1)-Hydroxylation of Fatty Acids* , 2004, Journal of Biological Chemistry.
[121] J. Whitlock. The regulation of cytochrome P-450 gene expression. , 1986, Annual review of pharmacology and toxicology.
[122] G. Winston,et al. Oxidation of thiodiglycol (2,2′‐thiobis‐ethanol) by alcohol dehydrogenase: Comparison of human isoenzymes , 2000, Journal of biochemical and molecular toxicology.
[123] J. Hansson,et al. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. , 1991, Cancer research.
[124] P. Crooks,et al. Physicochemical Evaluation, in Vitro Human Skin Diffusion, and Concurrent Biotransformation of 3-O-Alkyl Carbonate Prodrugs of Naltrexone , 2004, Pharmaceutical Research.
[125] T. Kissel,et al. The Human Keratinocyte Cell Line HaCaT: An In Vitro Cell Culture Model for Keratinocyte Testosterone Metabolism , 1999, Pharmaceutical Research.
[126] H. Swanson,et al. Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin. , 2003, Toxicology and applied pharmacology.
[127] H. Swanson. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. , 2004, Chemico-biological interactions.
[128] S. Slivka. Testosterone metabolism in an in vitro skin model , 1992, Cell Biology and Toxicology.
[129] S. Hotchkiss,et al. Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency. , 2003, Journal of dermatological science.
[130] Peter G. Zaphiropoulos,et al. RNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liver , 1999, Nucleic Acids Res..
[131] P. G. Wells,et al. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. , 1996, Cancer research.
[132] J. Marcos,et al. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. , 2004, European journal of biochemistry.
[133] J. Bridges,et al. UDP-glucuronosyltransferase activity in rat-and hairless mouse skin-microsomes. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.
[134] W. Sippl,et al. Skin Penetration and Metabolism of Topical Glucocorticoids in Reconstructed Epidermis and in Excised Human Skin , 1999, Pharmaceutical Research.
[135] R. Teshima,et al. mRNA Expression of Multiple Cytochrome P450 Isozymes in Four Types of Cultured Skin Cells , 2002, International Archives of Allergy and Immunology.
[136] N. Ledirac,et al. Carbaryl induces CYP1A1 gene expression in HepG2 and HaCaT cells but is not a ligand of the human hepatic Ah receptor. , 1997, Toxicology and applied pharmacology.
[137] P. Blain,et al. Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. , 1993, Biochemical pharmacology.
[138] G. Siest,et al. Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. , 1989, Biochemical pharmacology.
[139] E. Mayatepek,et al. S-Acetylglutathione normalizes intracellular glutathione content in cultured fibroblasts from patients with glutathione synthetase deficiency , 2004, Journal of Inherited Metabolic Disease.
[140] I. Phillips,et al. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. , 2001, Biochemical pharmacology.
[141] H. Rosenkranz,et al. Comparative effects of topically applied nitrated arenes and their nonnitrated parent arenes on cutaneous and hepatic drug and carcinogen metabolism in neonatal rats. , 1986, Toxicology and applied pharmacology.
[142] T. Ngawhirunpat,et al. Age difference in simultaneous permeation and metabolism of ethyl nicotinate in rat skin. , 2001, Biological & pharmaceutical bulletin.
[143] K. Wittern,et al. NAD(P)H:Quinone Reductase Activity in Human Epidermal Keratinocytes and Reconstructed Epidermal Models , 2002, Skin Pharmacology and Physiology.
[144] F. Oesch,et al. Specificity of human, rat and mouse skin epoxide hydratase towards K-region epoxides of polycyclic hydrocarbons. , 1978, Biochemical pharmacology.
[145] E. Jourdan,et al. Zinc‐metallothionein genoprotective effect is independent of the glutathione depletion in HaCaT keratinocytes after solar light irradiation , 2004, Journal of cellular biochemistry.
[146] J. Voorhees,et al. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo. , 1997, The Journal of investigative dermatology.
[147] H. Mukhtar,et al. Induction of CYP1A1 mRNA in rat epidermis and cultured human epidermal keratinocytes by benz(a)anthracene and beta-naphthoflavone. , 1992, Drug metabolism and disposition: the biological fate of chemicals.
[148] S. Boyce,et al. Methods for the Serum-Free Culture of Keratinocytes and Transplantation of Collagen-GAG-Based Skin Substitutes. , 1999, Methods in molecular medicine.
[149] M. Taimi,et al. CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. , 2004, The Journal of biological chemistry.
[150] R. Agarwal,et al. Purification and molecular characterization of beta-naphthoflavone-inducible cytochrome P-450 from rat epidermis. , 1992, The Journal of investigative dermatology.
[151] C. Chignell,et al. Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. , 2004, Chemical research in toxicology.
[152] Nesrin Emekli,et al. Melatonin reduces oxidative damage to skin and normalizes blood coagulation in a rat model of thermal injury. , 2005, Life sciences.
[153] A. Roberts,et al. Involvement of Smad Signaling in Sphingosine 1-Phosphate-mediated Biological Responses of Keratinocytes* , 2004, Journal of Biological Chemistry.
[154] J. Bridges,et al. Cytochrome P-450 dependent deethylase activity in rat and hairless mouse skin microsomes. , 1982, Biochemical pharmacology.
[155] K. Sayama,et al. A Novel Function of Angiotensin II in Skin Wound Healing , 2006, Journal of Biological Chemistry.
[156] H. Törmä,et al. Vitamin A esterification in human epidermis: a relation to keratinocyte differentiation. , 1990, The Journal of investigative dermatology.
[157] M. Mulero,et al. Parameters related to oxygen free radicals in erythrocytes, plasma and epidermis of the hairless rat. , 2002, Life sciences.
[158] M. Rerek,et al. Percutaneous Absorption of Sunscreens Through Micro-Yucatan Pig Skin In Vitro , 1999, Pharmaceutical Research.
[159] P. Capel,et al. Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase. , 1987, Gastroenterology.
[160] A. Y. Lu,et al. Cytochrome P450 in vitro reaction phenotyping: a re-evaluation of approaches used for P450 isoform identification. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[161] M. Briggs. Induction by topical corticosteroids of skin enzymes metabolizing carcinogenic hydrocarbons , 1973, The British journal of dermatology.
[162] G. Ailhaud,et al. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. , 2000, The Journal of investigative dermatology.
[163] Kaori Matsumoto,et al. Utility of a three-dimensional cultured human skin model as a tool to evaluate the simultaneous diffusion and metabolism of ethyl nicotinate in skin. , 2004, Drug metabolism and pharmacokinetics.
[164] T Kurihara-Bergstrom,et al. Characterization of the Yucatan miniature pig skin and small intestine for pharmaceutical applications. , 1986, Laboratory animal science.
[165] T. Boyer,et al. Characterization of glutathione S-transferase in cultured human keratinocytes. , 1991, The Journal of investigative dermatology.
[166] H. Mukhtar,et al. Differences in inducibility of cytochrome P-4501A1, monooxygenases and glutathione S-transferase in cutaneous and extracutaneous tissues after topical and parenteral administration of beta-naphthoflavone to rats. , 1993, The International journal of biochemistry.
[167] A. Honda,et al. Effect of YM 9429, a potent teratogen, on cholesterol biosynthesis in cultured cells and rat liver microsomes , 1996, Steroids.
[168] H. Jörnvall,et al. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. , 1999, Biochemical pharmacology.
[169] H. Mukhtar,et al. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. , 2000, The Journal of investigative dermatology.
[170] S. Shuster,et al. Induction of drug metabolising enzymes in the skin by topical steroids. , 1984, Journal of steroid biochemistry.
[171] Oliver Hankinson,et al. CYP2S1: a short review. , 2005, Toxicology and applied pharmacology.
[172] H. Mukhtar,et al. Cytochrome p450: a target for drug development for skin diseases. , 2004, The Journal of investigative dermatology.
[173] S. Roychowdhury,et al. Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin , 2005, The AAPS Journal.
[174] H. Glatt,et al. The apparent ubiquity of epoxide hydratase in rat organs. , 1977, Biochemical pharmacology.
[175] L. Wattenberg,et al. HISTOCHEMICAL DEMONSTRATION OF REDUCED PYRIDINE NUCLEOTIDE DEPENDENT POLYCYCLIC HYDROCARBON METABOLIZING SYSTEMS , 1962 .
[176] J. Mey,et al. Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models. , 2006, The Journal of investigative dermatology.
[177] F. Dilworth,et al. cDNA Cloning of Human Retinoic Acid-metabolizing Enzyme (hP450RAI) Identifies a Novel Family of Cytochromes P450 (CYP26)* , 1997, The Journal of Biological Chemistry.
[178] S. Hotchkiss,et al. Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse. , 1997, Toxicology and applied pharmacology.
[179] H. Glatt,et al. Interindividual comparison of epoxide hydratase and glutathione S-transferase activities in cultured human fibroblasts. , 1980, Carcinogenesis.
[180] M. Meurer,et al. Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents – a preliminary study , 1999, Archives of Dermatological Research.
[181] D. Migliore-Samour,et al. Cytochrome P450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation , 2001, The British journal of dermatology.
[182] R. Eckert,et al. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. , 1997, Physiological reviews.
[183] H. Mukhtar,et al. Age-related changes in benzo(a)pyrene metabolism and epoxide-metabolizing enzyme activities in rat skin. , 1983, Drug metabolism and disposition: the biological fate of chemicals.
[184] H. Mukhtar,et al. Glutathione-S-epoxide transferase in mouse skin and human foreskin. , 1976, The Journal of investigative dermatology.
[185] Franz Oesch,et al. Chapter 4 – Xenobiotic Metabolism , 1999 .
[186] P. G. Wells,et al. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin. , 1997, The Journal of pharmacology and experimental therapeutics.
[187] I. Bernstein,et al. Levels of cytochrome P-450-mediated aryl hydrocarbon hydroxylase (AHH) are higher in differentiated than in germinative cutaneous keratinocytes. , 1990, The Journal of investigative dermatology.
[188] K. Schittkowski,et al. Modeling of diffusion and concurrent metabolism in cutaneous tissue. , 2000, Journal of theoretical biology.
[189] S. Ekins,et al. The role of CYP2B6 in human xenobiotic metabolism. , 1999, Drug metabolism reviews.
[190] B. Lake,et al. Expression and alternative splicing of the cytochrome P-450 CYP2A7. , 1995, The Biochemical journal.
[191] P. G. Wells,et al. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. , 1995, Cancer research.
[192] C. Fritsch,et al. Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes , 1996, Archives of Dermatological Research.
[193] H. Volk,et al. Efficient in vitro transduction of epithelial cells and keratinocytes with improved adenoviral gene transfer for the application in skin tissue engineering. , 2002, Transplant immunology.
[194] W. Dressler,et al. Plasma/blood pharmacokinetics and metabolism after dermal exposure to para-aminophenol or para-phenylenediamine. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[195] T. Phillips,et al. Variation in sensitizing efficiency for SR 2508 in human cells dependent on glutathione content. , 1986, International journal of radiation oncology, biology, physics.
[196] G. Nohynek,et al. Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. , 2005, Toxicology letters.
[197] M. Fujii,et al. The effect of ethanol on the simultaneous transport and metabolism of methyl p-hydroxybenzoate in excised skin of Yucatan micropig. , 2002, International journal of pharmaceutics.
[198] I. Merkatz,et al. Induction of Benzo[α]pyrene Hydroxylase in Human Skin , 1972, Science.
[199] A. Billich,et al. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. , 2001, International journal of pharmaceutics.
[200] A. Mavon,et al. Skin absorption and metabolism of a new vitamin E prodrug, delta-tocopherol-glucoside: in vitro evaluation in human skin models. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[201] C. Gomez-Sanchez,et al. Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes , 2001, The Journal of Steroid Biochemistry and Molecular Biology.
[202] J. Stegeman,et al. On the species-specific biotransformation of dibenzo[a,l]pyrene. , 2006, Chemico-biological interactions.
[203] A. Malmström,et al. Glucocorticoids change the nucleotide and sugar nucleotide pool sizes in cultured human skin fibroblasts. , 1987, Archives of biochemistry and biophysics.
[204] R. Tukey,et al. Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties. , 1994, Archives of biochemistry and biophysics.
[205] N. A. Santagati,et al. Ketoprofen 1-Alkylazacycloalkan-2-one Esters as Dermal Prodrugs: In Vivo and In Vitro Evaluations , 2003, Drug development and industrial pharmacy.
[206] H. Mukhtar,et al. Cytochrome P-450 dependent metabolism of testosterone in rat skin. , 1987, Biochemical and biophysical research communications.
[207] B. Christ,et al. Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin. , 2003, ALTEX.
[208] A. Slominski,et al. Serotonin metabolism in rat skin: characterization by liquid chromatography-mass spectrometry. , 2004, Archives of biochemistry and biophysics.
[209] Amy Li,et al. Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny. , 2004, The Journal of clinical investigation.